Prosecution Insights
Last updated: November 20, 2026
Application No. 19/558,952

Apparatus and Methods for Clot Aspiration With Revolving Asymmetric Aspiration Zone

Final Rejection §102§103
Filed
Mar 06, 2026
Priority
Mar 04, 2025 — provisional 63/766,947 +5 more
Examiner
GEIGER, RACHAEL L
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Dragon Vascular Inc.
OA Round
2 (Final)
82%
Grant Probability
Favorable
3-4
OA Rounds
2y 0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 82% — above average
82%
Career Allowance Rate
102 granted / 124 resolved
+12.3% vs TC avg
Strong +18% interview lift
Without
With
+18.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
43 currently pending
Career history
175
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
47.6%
+7.6% vs TC avg
§102
38.2%
-1.8% vs TC avg
§112
11.3%
-28.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 124 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-2, 6-8, 10-21, 31, 33-39 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Zhao et al. (US 20250228588 A1). Regarding claim 1, Zhao discloses a system for removing clot from a blood vessel (paras. [0150]-[0153]), the system comprising: an aspiration catheter (i.e., as recited in para. [0150]) having a lumen extending therethrough (para. [0150]), an opening into the lumen (Figs. 17A-18B), and an annular guide assembly (80, 27, and the space between 80 and 27 as annotated below in Fig. 18A) within a distal end region of the lumen (para. [0154]); having an annular guide channel (i.e., between 80 and 27) formed on an inner wall of the distal end region of the lumen (Fig. 18B) and a clot disruptor assembly 30 configured to be positioned within the catheter (para. [0154]), the disruptor assembly comprising: a disruptor (i.e., spinner tip 40) at a distal end of the disruptor assembly having a distal face that is configured to partially occlude the opening into the lumen of the catheter (i.e., the distal end of the disruptor at least partially occludes the opening into the lumen of the catheter by way of extending through the catheter); a retention protrusion 82 proximal to the disruptor and configured to movably engage the annular guide assembly of the catheter, wherein the retention protrusion is received in the annular guide channel (i.e., Fig. 18B) to limit proximal and distal axial movement of the disruptor assembly in the lumen (i.e., para. [0154] discloses that the annular stop 80 cooperates with one or more stops on the spinner device 30 to limit distal movement of 30) while allowing for rotation of the retention protrusion (i.e., at least since base 84 is fixed to rotation shaft 32 such that it rotates (para. [0175]); and an elongated drive shaft 32 eccentrically coupled to the disruptor and configured to be rotated to drive revolution of the disruptor across the opening into the lumen of the catheter when the retention protrusion is engaged with the annular guide assembly of the catheter (paras. [0103]). PNG media_image1.png 315 252 media_image1.png Greyscale Regarding claim 2, Zhao discloses the system of claim 1. Zhao also discloses Zhao also discloses wherein the annular guide assembly comprises a three-part construction stop band assembly 80, 27 including a proximal stop band 27, a distal stop band 80, and a middle spacer band (Fig. 18A above) defining the annular guide channel therebetween (Fig. 18A). Regarding claim 6, Zhao discloses the system of claim 1. Zhao also discloses wherein the distal face of the disruptor is configured to occlude between 30%-95% of the opening into the lumen of the catheter when the retention protrusion is engaged with the annular guide assembly (Fig. 18B shows at least occluding between 30%-95% of the opening into the lumen of the catheter). Regarding claim 7, Zhao discloses the system of claim 1. Zhao also discloses wherein the disruptor comprises a disc-shaped disruptor (i.e., 40 includes pieces 43, 45, which when taking at a cross section is disc shaped) having a planar structure oriented in a plane normal to a central axis of the catheter lumen (Fig. 18A). Regarding claim 8, Zhao discloses the system of claim 1. Zhao also discloses wherein at least a portion of the distal face of the disruptor is radiopaque (para. [0106]) and a portion of the annular guide assembly is radiopaque (para. [0106]) so as to facilitate engagement of the retention protrusion with the annular guide assembly (para. [0106]). Regarding claim 10, Zhao discloses the system of claim 1. Zhao also discloses wherein the disruptor is substantially flush with lumen opening (Fig. 18B). Regarding claim 11, Zhao discloses the system of claim 1. Zhao also discloses wherein the retention protrusion comprises one or more of: a retention ring (para. [0154]), one or more wings or arms 86, and a split ring. Regarding claim 12, Zhao discloses the system of claim 1. Zhao also discloses wherein the retention protrusion comprises a circular retention ring 82 received in the annular guide channel of the annular guide assembly (para. [0154] i.e., at least since it circumferential). Regarding claim 13, Zhao discloses the system of claim 12. Zhao also discloses wherein the circular retention ring is disposed between distal and proximal stop bands of the annular guide assembly (Fig. 18B). Regarding claim 14, Zhao discloses the system of claim 12. Zhao also discloses wherein the circular retention ring has an outer diameter approximately equal to an inner diameter of the distal end region of the aspiration catheter lumen (Fig. 18B) and comprises a distal bearing surface which engages a distal bearing surface of the annular guide assembly (i.e., the distal bearing surface is on the proximal side of the distal ring of 80 which is interpreted under BRI as being a distal bearing surface since 27 would be the proximal surface). Regarding claim 15, Zhao discloses the system of claim 14. Zhao also discloses wherein the circular retention ring further comprises a proximal bearing surface which engages a proximal bearing surface of the annular guide assembly (i.e., at least in the retracted position such that it contacts 27). Regarding claim 16, Zhao discloses the system of claim 15. Zhao also discloses wherein the distal and proximal bearing surfaces on the annular guide assembly are axially spaced apart to form an annular slot for rotationally receiving the circular retention ring (Fig. 18B). Regarding claim 17, Zhao discloses the system of claim 12. Zhao also discloses wherein the circular retention ring comprises a gap (i.e., at least between the edge and the inner surface of the catheter). Zhao is fully capable of having the retention ring elastically contract as the circular retention ring is inserted into the annular guide assembly, if one desired to do so - note that the limitations of claim 17 are merely functional limitations and do not affect the structure of the claimed invention - a claim containing a "recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus" if the prior art apparatus teaches all the structural limitations of the claim. Ex parte Masham, 2 USPQ2d 1647 (Bd. Pat. App. & Inter. 1987) -see also MPEP 2114(11), which states that the manner of operating a device does not differentiate apparatus claims from the prior art). Regarding claim 18, Zhao discloses the system of claim 12. Zhao also discloses wherein the disruptor and the circular retention ring are joined by an axial strut (Fig. 18B). Regarding claim 19, Zhao discloses the system of claim 18. Zhao also discloses wherein a distal end of the axial strut is connected to a connection point on a periphery of the circular retention ring and has a dog leg configured to position the connection point immediately adjacent to an inner wall of the distal end region of the lumen as the disruptor is revolved or rotated (see Fig. 18B, the dog leg 86 is connected to a connection point on 80). Regarding claim 20, Zhao discloses the system of claim 12. Zhao also discloses wherein the circular retention ring comprises a C-shaped retention element having two wings separated by a gap (i.e., the “C” shape is between each of the wings 86 and has a gap extending between the wings). Regarding claim 21, Zhao discloses the system of claim 12. Zhao also discloses further comprising a non-rotating sleeve extending over at least a proximal length of the elongated drive shaft, wherein the elongated drive shaft is configured to rotate relative to the sleeve (para. [0100] discloses another sleeve to protect the inner surface of the catheter 20 while shaft 32 rotates at high speeds). Regarding claim 31, Zhao discloses the system of claim 1. Zhao also discloses wherein the distal face of the disrupter assembly is maintained at a distance in a range of 0 to 0.5mm from a distal end of the catheter (Fig. 18B shows the distal face is maintained at about 0mm from the distal end). Regarding claim 33, Zhao discloses a system for removing clot from a blood vessel (paras. [0150]-[0153]), the system comprising: an aspiration catheter (i.e., as recited in para. [0150]) having a lumen extending therethrough (para. [0150]), an opening into the lumen (Figs. 17A-19B), and an annular guide assembly (80, 27, and the space between 80 and 27 as shown above) having an annular guide channel (i.e., the space as shown above) within a distal end region of the lumen (Fig. 18A); and a clot disruptor assembly 30 configured to be positioned within the catheter (para. [0154]), the disruptor assembly comprising: a disruptor (i.e., spinner tip 40) at a distal end of the disruptor assembly having a distal face that is configured to partially occlude the opening into the lumen of the catheter (i.e., as shown in Fig. 18B);a retention protrusion 82 proximal to the disruptor (Fig. 18B) and configured to movably engage the annular guide assembly of the catheter (Fig. 18A reproduced above), wherein the retention protrusion is received and locked within the annular guide channel to limit proximal and distal axial movement of the disruptor assembly in the lumen (i.e., para. [0154] discloses that the annular stop 80 cooperates with one or more stops on the spinner device 30 to limit distal movement of 30) while allowing for rotation of the retention protrusion (i.e., at least since base 84 is fixed to rotation shaft 32 such that it rotates (para. [0175]); and an elongated drive shaft 32 eccentrically coupled to the disruptor and configured to be rotated to drive revolution of the disruptor across the opening into the lumen of the catheter when the retention protrusion is engaged with the annular guide assembly of the catheter (paras. [0103]). Regarding claim 34, Zhao discloses the system of claim 33. Zhao also discloses wherein disrupter and the retention protrusion are joined by an axial strut connected to the elongated drive shaft (Fig. 18B). Regarding claim 35, Zhao discloses the system of claim 34. Zhao also discloses wherein a distal end of the axial strut is connected to a connection point on a periphery of the retention protrusion and has a dog leg that positions the connection point immediately adjacent to an inner wall of the distal end region of the lumen as the disruptor is rotated (see Fig. 18B, the dog leg 86 is connected to a connection point on 80). Regarding claim 36, Zhao discloses the system of claim 33. Zhao also discloses wherein the retention protrusion comprises a circular retention ring (para. [0154] i.e., at least since it circumferential). Regarding claim 37, Zhao discloses the system of claim 36. Zhao also discloses wherein the circular retention ring comprises a C- shaped retention element having two wings separated by a gap (i.e., the “C” shape is between each of the wings 86 and has a gap extending between the wings). Regarding claim 38, Zhao discloses the system of claim 36. Zhao also discloses wherein the circular retention ring has at least one cutout (i.e., between the wings). Regarding claim 39, Zhao discloses the system of claim 33. Zhao also discloses wherein the distal face of the disrupter assembly is maintained at a distance in a range of 0 to 0.5 mm from a distal end of the catheter (Fig. 18B shows the distal face is maintained at about 0mm from the distal end). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 3-5, 9 are rejected under 35 U.S.C. 103 as being unpatentable over Zhao. Regarding claim 3, Zhao discloses the system of claim 2. Zhao doesn’t directly disclose: wherein the annular guide channel has an axial height in range from 0.254 mm to 1.27 mm. Zhao does disclose dimension of the annular guide assembly needs to be optimized to be compatible with the spinner that fall within the claimed ranges (see paras. [0109], [0154], [0164]) such that Zhao at least discloses modifying the dimensions of the annular guide assembly). Further, it appears that one of ordinary skill in the art would have had a reasonable expectation of success in modifying the Zhao device to have the annular guide channel has an axial height within the claimed range, as it involves only adjusting the dimension of a component disclosed to require adjustment. Therefore, it would have been obvious to one having ordinary skill in the art at the time of the invention to modify the device of Zhao by making the annular guide channel has an axial height in range from 0.254 mm to 1.27 mm as a matter of routine optimization since it has been held that “where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). Regarding claim 4, Zhao discloses the system of claim 1. Zhao doesn’t directly disclose: wherein the annular guide assembly is between 2mm and 5cm from a distal end of the catheter. Zhao does disclose that the dimension of the annular guide assembly needs to be optimized relative to the tip of the device and each additional feature such that the annular guide assembly is limited in distal movement of the spinner device (see paras. [0154], [0164]). Further, it appears that one of ordinary skill in the art would have had a reasonable expectation of success in modifying the Zhao device to have the annular guide assembly within the claimed range, as it involves only adjusting the dimension of a component disclosed to require adjustment. Therefore, it would have been obvious to one having ordinary skill in the art at the time of the invention to modify the device of Zhao by making the annular guide assembly is between 2mm and 5cm from a distal end of the catheter as a matter of routine optimization since it has been held that “where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). Regarding claim 5, Zhao discloses the system of claim 1. Zhao doesn’t directly disclose wherein the retention protrusion has an axial height in a range from 0.127 mm to 1.0 mm. Zhao does disclose that the dimension of the retention protrusion needs to be optimized such that the annular guide assembly is limited in distal movement of the spinner device (see paras. [0154], [0164]). Further, it appears that one of ordinary skill in the art would have had a reasonable expectation of success in modifying the Zhao device to have the retention protrusion has an axial height within the claimed range, as it involves only adjusting the dimension of a component disclosed to require adjustment. Therefore, it would have been obvious to one having ordinary skill in the art at the time of the invention to modify the device of Zhao by making the retention protrusion has an axial height in a range from 0.127 mm to 1.0 mm as a matter of routine optimization since it has been held that “where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). Regarding claim 9, Zhao discloses the system of claim 1. Zhao doesn’t directly disclose wherein the retention protrusion is positioned between 1 mm and 5 cm from the disruptor. There is no evidence of record that establishes that changing the distance of the disruption protrusion from the disruptor would result in a difference in function of the Zhao device. Further, a person having ordinary skill in the art, being faced with modifying the retention protrusion of Zhao would have a reasonable expectation of success in making such a modification and it appears the device would function as intended being given the claimed distance. Lastly, applicant has not disclosed that the claimed range solves any stated problem, indicating that the angle “may” be within the claimed range, (e.g., specification at para. [0180]) and therefore there appears to be no criticality placed on the range as claimed such that it produces an unexpected result. Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the retention protrusion has an axial height in a range from 0.127 mm to 1.0 mm as an obvious matter of design choice within the skill of the art. Claim 32 is rejected under 35 U.S.C. 103 as being unpatentable over Zhao in view of Zeng et al. (US 20250331874 A1). Regarding claim 32, Zhao discloses the system of claim 1. Zhao doesn’t directly disclose wherein a center of disrupter rotation is offset from a central axis of the aspiration catheter lumen. In the same field of endeavor, namely systems and methods for restoring blood vessel patency, Zeng discloses a similar device to Zhao and includes a clot disruptor 104 and further discloses a center of disrupter rotation is offset from a central axis of the aspiration catheter lumen (Fig. 1C shows at least a portion (i.e., at 126/136, 128/138, 124/134) being offset. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the device of Zhao such that a center of disrupter rotation is offset from a central axis of the aspiration catheter lumen as disclosed by Zeng for purposes of having varying outer diameter that applies significantly less radial force to the wall of the bodily lumen (para. [0038]). Response to Arguments Applicant's arguments filed 9/4/26 have been fully considered but they are not persuasive in light of the new interpretation as discussed further above and with regard to Figure 18A above which has been annotated to more clearly point out the interpretation. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RACHAEL LYNN GEIGER whose telephone number is (571)272-6196. The examiner can normally be reached Mon-Fri 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached at 5712724695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RACHAEL L GEIGER/Examiner, Art Unit 3771 /BROOKE LABRANCHE/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Mar 06, 2026
Application Filed
Jul 29, 2026
Non-Final Rejection mailed — §102, §103
Sep 01, 2026
Examiner Interview Summary
Sep 04, 2026
Response Filed
Sep 28, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12797100
ENDOSCOPE TREATMENT TOOL, ENDOSCOPE DEVICE, AND TREATMENT METHOD
3y 6m to grant Granted Nov 17, 2026
Patent 12797195
RING CONTRACTION APPARATUS FOR MITRAL VALVE ANNULUS
2y 12m to grant Granted Nov 17, 2026
Patent 12746025
MEDICAL DEVICE HANDLE ASSEMBLIES AND METHODS OF USING THE SAME
2y 4m to grant Granted Sep 29, 2026
Patent 12714449
CONTROL OF IVL SYSTEMS, DEVICES AND METHODS THEREOF
1y 4m to grant Granted Aug 25, 2026
Patent 12708371
EMBOLIZATION DEVICE
4y 3m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
82%
Grant Probability
99%
With Interview (+18.3%)
2y 9m (~2y 0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 124 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month